What does the presence of small lymphocytes with round nuclear contours, coarsely clumped chromatin, and inconspicuous nucleoli indicate?

Morphologic Description Consistent with Chronic Lymphocytic Leukemia (CLL)

The presence of small lymphocytes with round nuclear contours, coarsely clumped (partially aggregated) chromatin, and inconspicuous nucleoli is the characteristic morphologic appearance of chronic lymphocytic leukemia (CLL) cells. 1, 2, 3

Diagnostic Significance

This morphologic description represents the hallmark cytologic features that define CLL on blood smear examination. According to established diagnostic criteria, these cells must be:

• Small, mature-appearing lymphocytes
• Narrow rim of cytoplasm
• Dense nucleus lacking discernible nucleoli
• Partially aggregated (coarsely clumped) chromatin
• Round nuclear contours (though up to 55% may show atypical or larger forms including prolymphocytes) 2

Completing the Diagnosis

Morphology alone is insufficient for diagnosis - the following are mandatory:

Required Confirmatory Testing:

• Flow cytometry to confirm B-cell clonality and characteristic immunophenotype (CD5+, CD19+, CD20+, CD23+, with dim surface immunoglobulin and kappa or lambda light chain restriction) 1, 3
• Absolute lymphocyte count ≥5,000/µL (5 × 10⁹/L) sustained for at least 3 months 1, 2, 3

Important Caveats:

If the lymphocyte count is <5,000/µL:

• With lymphadenopathy/organomegaly → diagnose as Small Lymphocytic Lymphoma (SLL) 3
• Without lymphadenopathy/organomegaly/cytopenias → diagnose as Monoclonal B-cell Lymphocytosis (MBL), which progresses to CLL at 1-2% per year 2

Differential Diagnosis to Exclude

The morphology described must be distinguished from other CD5+ B-cell malignancies:

• Mantle cell lymphoma - typically CD23-negative, cyclin D1+, t(11;14) 1
• Prolymphocytic leukemia - >55% prolymphocytes with prominent nucleoli 2, 4
• Marginal zone lymphoma - CD5-negative or weak, CD23-negative 3

Additional Morphologic Features Supporting CLL

Look for Gumprecht nuclear shadows (smudge cells) - these are characteristic cell debris found in CLL specimens and support the diagnosis 2.

Nuclear irregularities or clefts in >5% of cells may indicate a higher-risk subgroup, though this does not change the fundamental diagnosis 5, 6.

Next Steps After Morphologic Recognition

Once this morphology is identified:

1. Confirm diagnosis with flow cytometry immunophenotyping 1, 3
2. Obtain FISH for del(17p), del(11q), trisomy 12, del(13q) before treatment 1, 7
3. Test IGHV mutational status before first treatment 3, 7
4. Screen for TP53 mutations before treatment 3, 7

The morphologic description you've provided is essentially pathognomonic for CLL when confirmed by appropriate immunophenotyping, representing the most common leukemia in Western adults with a median age at diagnosis of 72 years 1, 3.